Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study

  • Luca Cindolo1, 14Email authorView ORCID ID profile,
  • Clara Natoli2,
  • Cosimo De Nunzio3,
  • Michele De Tursi2,
  • Maurizio Valeriani4,
  • Silvana Giacinti5,
  • Salvatore Micali6,
  • Mino Rizzo6,
  • Giampaolo Bianchi6,
  • Eugenio Martorana6,
  • Marcello Scarcia7,
  • Giuseppe Mario Ludovico7,
  • Pierluigi Bove8,
  • Anastasia Laudisi9,
  • Oscar Selvaggio10,
  • Giuseppe Carrieri10,
  • Maida Bada1,
  • Pietro Castellan1,
  • Stefano Boccasile11,
  • Pasquale Ditonno11,
  • Paolo Chiodini12,
  • Paolo Verze13,
  • Vincenzo Mirone13 and
  • Luigi Schips1
BMC Cancer201717:753

https://doi.org/10.1186/s12885-017-3755-x

Received: 13 January 2017

Accepted: 6 November 2017

Published: 10 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Jan 2017 Submitted Original manuscript
7 Feb 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 2
7 Feb 2017 Submitted Manuscript version 2
1 May 2017 Reviewed Reviewer Report - David F Jarrard
25 Jun 2017 Reviewed Reviewer Report - Klaus Brasso
13 Jul 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 3
13 Jul 2017 Submitted Manuscript version 3
18 Jul 2017 Reviewed Reviewer Report - Klaus Brasso
8 Aug 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 4
8 Aug 2017 Submitted Manuscript version 4
14 Sep 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 5
14 Sep 2017 Submitted Manuscript version 5
6 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 6
6 Oct 2017 Submitted Manuscript version 6
30 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 7
30 Oct 2017 Submitted Manuscript version 7
Publishing
6 Nov 2017 Editorially accepted
10 Nov 2017 Article published 10.1186/s12885-017-3755-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Urology, ASL Abruzzo2
(2)
Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell’Invecchiamento e Medicina Traslazionale (CeSI-MeT)
(3)
Department of Urology, “Sant’Andrea” Hospital , Sapienza University”
(4)
Radiation therapy Unit, “Sant’Andrea” Hospital, “Sapienza University”
(5)
Oncology Unit, “Sant’Andrea” Hospital, “Sapienza University”
(6)
Department of Urology, University of Modena & Reggio Emilia, Baggiovara Hospital
(7)
Ente Ecclesiastico Ospedale “F. Miulli”
(8)
Department Of Experimental Medicine and Surgery, Azienda Policlinico Tor Vergata
(9)
UOSD of Medical Oncology Azienda Policlinico Tor Vergata
(10)
Department of Urology, University of Foggia
(11)
Urology and Andrology Unit II, Department of Emergency and Organ Transplantation, University of Bari
(12)
Medical Statistics Unit, University of Campania “Luigi Vanvitelli”
(13)
Department of Neurosciences, Sciences of Reproduction and Odontostomatology, Urology Unit, University of Naples “Federico II”
(14)
Department of Urology, ASL Abruzzo2 , “S. Pio da Pietrelcina” Hospital

Advertisement